CONCLUSION: The serum GABA/Glu ratio may serve as a promising biomarker for the auxiliary diagnosis, severity assessment, and treatment monitoring of ADHD. However, further independent validation is required before clinical application.
CONCLUSION: The serum GABA/Glu ratio may serve as a promising biomarker for the auxiliary diagnosis, severity assessment, and treatment monitoring of ADHD. However, further independent validation is required before clinical application.